Assignee
ALIGOS THERAPEUTICS INC
US·35 granted patents·31 pending applications·46 citations·filing 2019–2025
Top patents by PatentIndex Score
66 records- 0197US11851422B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·8 cites·61 claims
- 0297US11091467B2Modulators of THR-β and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2020·Granted Aug 17, 2021·6 cites·17 claims
- 0395US11549110B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Granted Jan 10, 2023·5 cites·30 claims
- 0495US11191747B2Pyrrole compoundsALIGOS THERAPEUTICS INC·Filed 2020·Granted Dec 7, 2021·3 cites·30 claims
- 0595US11136321B2Tricyclic compoundsALIGOS THERAPEUTICS INC·Filed 2020·Granted Oct 5, 2021·4 cites·20 claims
- 0692US12129469B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·1 cites·30 claims
- 0792US12018015B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·2 cites·21 claims
- 0892US11952365B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·2 cites·18 claims
- 0992US11820773B2Tricyclic compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Nov 21, 2023·2 cites·21 claims
- 1090US11771680B2Pyrrole compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Oct 3, 2023·1 cites·19 claims
- 1190US11760761B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·26 claims
- 1289US12065428B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Aug 20, 2024·1 cites·23 claims
- 1389US11760764B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·24 claims
- 1488US11957683B2Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·1 cites·46 claims
- 1588US11952374B2Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·1 cites·21 claims
- 1685US11166976B2S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·1 cites·6 claims
- 1783US2025304561A1Modulators of thr-beta and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1882US12252481B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Granted Mar 18, 2025·0 cites·23 claims
- 1982US11033556B2Bicyclic sulfonamidesALIGOS THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·1 cites·27 claims
- 2081US11466274B2Modified gapmer oligonucleotides and methods of useALIGOS THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·1 cites·16 claims
- 2181US11198699B2Compounds targeting PRMT5ALIGOS THERAPEUTICS INC·Filed 2020·Granted Dec 14, 2021·1 cites·26 claims
- 2280US2026002157A1MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOFALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2379US11591341B2Bicyclic and tricyclic compoundsALIGOS THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·1 cites·30 claims
- 2478US2023332153A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2577US12534450B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2024·Granted Jan 27, 2026·0 cites·19 claims
- 2676US12454691B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Granted Oct 28, 2025·0 cites·29 claims
- 2771US12180192B2Modulators of THR-β and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Dec 31, 2024·0 cites·23 claims
- 2870US2022364096A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2969US2025243187A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3066US2024199647A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3166US2024182444A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3266US2022125825A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3366US2023383296A1Modified gapmer oligomers and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3466US2024352464A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3565US2024018126A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3665US2022048922A1Compounds targeting prmt5ALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3765US2024150351A1Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3864US2023382909A1Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3964US2024277706A1Methods and compostitions for targeting pd-l1ALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4063US12384779B2Bicyclic compoundsALIGOS THERAPEUTICS INC·Filed 2023·Granted Aug 12, 2025·0 cites·18 claims
- 4162US2025206725A1Modulators of thr-beta and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4260US12428427B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2022·Granted Sep 30, 2025·0 cites·23 claims
- 4360US11858913B2Bicyclic pyridazinones and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·0 cites·18 claims
- 4459US11840532B2Modulators of THR-β and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·12 claims
- 4559US11793815B2Oxindoles and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Oct 24, 2023·0 cites·23 claims
- 4659US11786532B22-pyridones and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·0 cites·19 claims
- 4759US2022160748A1Conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targetingALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4858US2022000874A1Tricyclic compoundsALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4957US2025382618A1Methods and compositions for inhibiting virusALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 5057US2025243491A1Pnpla3-targeting short interfering rna (sirna) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ALIGOS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →